With a 9.8% increase in sales, the Company outperforms the market and gains market share in its leading areas Both the Group’s Ebitda and Operating Profit show significant increases of 47% and 71%, respectively The Board of Directors approves the distribution of a final dividend of 0.227 euros per share for the 2023 financial year, […]
This new revelation makes the Neurosurgery Service at the Hospital La Paz in Madrid the first public or private hospital in the country to offer the state-of-the-art Excelsius GPS technology for back surgery. To date this equipment has been used to perform 37 operations and fit 220 screws in patients. “This innovative technology allows us […]
On Monday 6 November, the launch meeting of the SpineAI project was held. It took place at the IDONIAL technology centre facilities at the Gijón Science and Technology Park and brought together all the cooperating entities who will work on the development of this pioneering and innovative initiative: the IDONIAL, FINBA and UC3M R+D+i centres […]
The Company achieved an 11.2% increase in EBITDA, amounting to an accumulated €17.7 million in the third quarter. The PRIM Group has strengthened its growth during the first nine months of the year, with an 8.8% increase in its net turnover, which reached €154.8 million. This improvement fulfils one of the targets set out […]
Both institutions have agreed to conduct research in order to corroborate the usefulness of the ocular motility of the Oscann™ device for the early and progressive diagnosis of Alzheimer’s and Parkinson’s disease. The research will be carried out at the HM Madrid University Hospital, and it is estimated that the cohort study will involve […]
According to data from the Spanish Society of Neurology (SEN), neurological diseases affect more than 7 million people in Spain. Their early diagnosis is essential to improve the prognosis and quality of life for patients and to provide them with the appropriate care. However, these diseases, such as Alzheimer’s, Parkinson’s and amyotrophic lateral sclerosis (ALS), usually […]
The Board of Trustees of the Institute for the Development and Integration of Health (the IDIS Foundation) has approved the inclusion of PRIM as a new sponsor, resulting in it becoming one of the 23 entities that make up the IDIS Foundation group. The IDIS Foundation is a non-profit organisation that aims to highlight the […]
The medical technology company saw 17% growth in 2022, which is far beyond the 4% figure seen in the market as a whole It reached €197 million in revenue last year, confirming the success of its 21/25 Strategic Plan The PRIM Group continues to stand strong as a leading manufacturer and distributer in the healthcare […]
